Risk Factors of Cardiotoxicity After Breast Cancer Radiation Therapy
In a cohort of patients with breast cancer with low CAC burden and overall low doses of radiation, we observed low rates of cardiotoxicity. However, our findings identify patients with nodal positive disease as a particularly high-risk group, suggesting that close follow-up and optimization of therapies for this subgroup is needed.
Authors
- Santino Butler (ORCID: https://orcid.org/0000-0003-4157-9437)
- Felicia Guo (ORCID: https://orcid.org/0000-0001-7122-4827)
- Michael S. Binkley (ORCID: https://orcid.org/0000-0002-2640-5255)
- Scott Jackson (ORCID: https://orcid.org/0000-0002-0062-3131)
- Daniel E. Clark (ORCID: https://orcid.org/0000-0002-8054-0642)
- H.J. No (ORCID: https://orcid.org/0000-0002-4285-5141)
- Kathleen Claire Horst
- Carol Marquez
- June-Wha Rhee
- Natalie Park
Institutions
- Kaiser Permanente (US)
- Palo Alto University (US)
- City of Hope (US)
- Stanford Medicine (US)
- University of Rochester (US)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.adro.2025.101911
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39